Company Filing History:
2 out of 453 
1 out of 5 Years Active: 2022
Title: The Innovations of Pablo Peñalver Puente
Introduction
Pablo Peñalver Puente is a notable inventor based in Granada, Spain. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds for treating various diseases. With a total of 2 patents, his work focuses on innovative therapeutic solutions.
Latest Patents
Pablo's latest patents include "Silylated derivatives of resveratrol and the use thereof in neurodegenerative, neurological or inflammatory diseases." This invention relates to a group of compounds derived from resveratrol, which possess at least one silyl group that can be substituted by different groups. The therapeutic applications of these compounds target inflammatory, neurological, and neurodegenerative diseases. Another significant patent is "Acylated compounds for the treatment of ocular pathologies." This invention addresses the therapeutic use of acylated piceid derivative compounds specifically for ocular conditions, including retinitis pigmentosa and age-related macular degeneration.
Career Highlights
Throughout his career, Pablo has worked with esteemed organizations such as the Consejo Superior de Investigaciones Científicas and the Fundación Pública Andaluza Progreso y Salud. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Pablo has collaborated with notable colleagues, including Juan Carlos Morales Sánchez and Efres Belmonte Reche. These partnerships have enriched his research endeavors and fostered innovation in his field.
Conclusion
Pablo Peñalver Puente's contributions to medicinal chemistry through his patents demonstrate his commitment to addressing critical health issues. His innovative approaches in developing therapeutic compounds highlight the importance of research and collaboration in advancing medical science.